Citicoline protects hippocampal neurons against apoptosis induced by brain β-amyloid deposits plus cerebral hypoperfusion in rats

被引:43
作者
Alvarez, XA [1 ]
Sampedro, C
Lozano, R
Cacabelos, R
机构
[1] EuroEspes Biomed Res Ctr, Dept Neuropharmacol, La Coruna 15166, Spain
[2] Ferrer Int, Barcelona, Spain
来源
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY | 1999年 / 21卷 / 08期
关键词
citicoline; apoptosis; neuronal degeneration; memory; hippocampus; rat;
D O I
10.1358/mf.1999.21.8.794835
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Citicoline is an endogenous intermediate involved in the biosynthesis of brain phospholipids and acetylcholine which has been extensively used for the treatment of several neurodegenerative conditions. The effects of citicoline on neurodegeneration, apoptosis and learning were investigated in male Sprague Dawley rats subjected to implants of the beta-amyloid fragment 1-40 (A beta 4; 3 Mmol) into the light hippocampus and to permanent unilateral occlusion of the carotid artery Citicoline (CDP: 0, 62.5, 125 and 250 mg/kg/day i.p.) was given during 2 days before and for 5 days after surgery, and the extension of the degeneration and the number of apoptotic figures (TUNEL technique) were evaluated in the dentate gyrus (DG) and the CA1 area of the the hippocampus. Citicoline, at 125 and 250 mg/kg, reduced the number of apoptotic neurons in the hippocampus of rats mts with A beta 4/hypoper-fusion-induced neurodegeneration (CDP0 = 105.3 +/- 32.8 apoptotic figures; CDP125 = 39.2 +/- 7.4** apoptotic figures; CDP250 = 34.5 +/- 14.4** apoptotic figures; **p < 0.01 vs. CDP0). CDP also reduced neuronal degeneration in file CA1 area in a dose-dependent manner-(CDP0 = 450.5 +/- 130.1 mu m; CDP62.5 = 280.6 +/- 76.3 mu m; CDP125 = 86.6 +/- 37.3* mu m; CDP250 = 121.7 +/- 85.3* mu m; p < 0.05 vs. CDP0). Variability of results was very high in the DG, where a significant reduction in the extent of neurodegeneration was only observed in the group of rats receiving 2.5 mg/kg of citicoline. Finally, citicoline improved retention of a passive avoidance learning task, increasing th number of avoidances (Av) (CDP0 = 4.2 +/- 0.7 Av; CDP62.5 = 6.9 +/- 1.0 Av; CDP125 = 7.9 +/- 0.7** Av; CDP250 = 8.5 +/- 0.6** Av; **p < 0.01 vs. CDP0) in a dose-related manner. Based on these results, it was concluded that citicoline exerts antiapoptotic, neuroprotective and antiamnestic effects in conditions of neurodegeneration induced by A beta 4 plus hypoperfusion. (C)1999 Prous Science. All rights reserved.
引用
收藏
页码:535 / 540
页数:6
相关论文
共 25 条
[1]  
Alvarez XA, 1997, METHOD FIND EXP CLIN, V19, P471
[2]  
Alvarez XA, 1997, METHOD FIND EXP CLIN, V19, P201
[3]  
Alvarez XA, 1997, HUM PSYCHOPHARM CLIN, V12, P547, DOI 10.1002/(SICI)1099-1077(199711/12)12:6<547::AID-HUP922>3.0.CO
[4]  
2-T
[5]  
ALVAREZ XA, 1998, PROGR ALZHEIMERS PAR, P699
[6]  
ALVAREZ XA, 1998, 5 INT GEN SPRINGF S, P135
[7]  
ALVAREZ XA, 1996, 4 NIC SPRINGF S ADV, P131
[8]   Therapeutic effects of CDP-choline in Alzheimer's disease - Cognition, brain mapping, cerebrovascular hemodynamics, and immune factors [J].
Cacabelos, R ;
Caamano, J ;
Gomez, MJ ;
FernandezNovoa, L ;
FrancoMaside, A ;
Alvarez, XA .
NEUROBIOLOGY OF ALZHEIMER'S DISEASE, 1996, 777 :399-403
[9]  
Cacabelos Ramon, 1994, Drugs of Today, V30, P295
[10]  
Cotman CW, 1998, ADV BEHAV BIOL, V49, P45